Common Contracts
1 similar Study Agreement contracts
FIRST AMENDMENT TO CLINICAL STUDY AGREEMENT PRVNÍ DODATEK KE SMLOUVĚ O KLINICKÉM HODNOCENÍ EU GENERAL DATA PROTECTION REGULATION (“GDPR”) – DATA PROCESSING REQUIREMENTS OBECNÉ NAŘÍZENÍ EU O OCHRANĚ OSOBNÍCH ÚDAJŮ (dále jen „GDPR“) – POŽADAVKY NA...Study Agreement • January 22nd, 2019
THIS FIRST AMENDMENT TO CLINICALSTUDY AGREEMENT (this “Amendment”) is made and entered into by and between Pfizer Inc, a Delaware Corporation with a place of business at 235 East 42nd Street, New York, NY 10017-5755, USA (“Pfizer”), Thomayerova nemocnice, with a place of business at Vídeňská 800/5, 140 00 Praha 4, Czech Republic, Idenitification number: 00064190, Tax Indentification number: CZ00064190, represented by doc. MUDr. Zdeňek Beneš, CSc., Director, Registered in Commercial Register kept by the Municipal Court in Prague, section Pr, insert 1043, Contributory organization founded by the Ministry of Health of the Czech Republic, full text of the Foundation Deed No MZDR 17268-IV/2012 (“Institution”), and Doc. XXXXXXXXXXXXXXX of Thomayerova nemocnice Vídeňská 800/5, 140 00 Praha 4 (“Principal Investigator”), (Pfizer, Institution and Principal Investigator collectively the “Parties”), effective as of 25 May 2018, the date on which the GDPR will enter into force (the “Amendment Effec
